A Phase I clinical trial to assess the safety and immunogenicity of administering MVA-CMDR vaccine, carrying HIV-1 genes env, gag, and pol in subjects who have previously received plasmid DNA with analogous HIV-1 genes in HIVIS 01

Trial Details:

I Completed
Karolinska Institute, Swedish Institute for Infectious Disease Control, US Military HIV Research Program January 01, 2006
MVA-CMDR gag-pol CM 240, env CM235
MVA-CMDR Viral Vector - Pox
Sweden 38